Slides From Advanced Therapies for Ulcerative Colitis: A Critical Look at Comparative Data

Explore the comparable efficacy, risks, and real-world data on specific biologic and small molecules therapies for treating moderate to severe ulcerative colitis.
Gary Lichtenstein Headshot
Gary R. Lichtenstein, MD
Uma Mahadevan, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1,007 KB
Released: January 24, 2020

Acknowledgements

Provided by the American Gastroenterological Association
American Gastroenterological Association (AGA)
4930 Del Ray Avenue
Bethesda, MD 20814
Phone: (301) 654-2055
Fax: (301) 654-5920
Email: member@gastro.org
Supported by an educational grant from
Takeda Pharmaceuticals USA, LLC

Related Content

Expert slides from Clinical Care Options (CCO) on optimal management of inflammatory bowel disease (IBD), including ulcerative colitis, Crohn disease

Uma Mahadevan, MD William Sandborn, MD Released: September 22, 2020

New from EULAR 2020, Clinical Care Options (CCO): adults with immune-mediated inflammatory disease report biologic-associated fatigue in Dutch Biologic Monitor

Released: August 13, 2020

Uma Mahadeven, MD, and Marla Dubinsky, MD: expert commentary on preconception strategies to ensure safe, effective IBD control before and during pregnancy

Marla Dubinsky, MD Uma Mahadevan, MD Released: March 25, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue